Skip to main content
Premium Trial:

Request an Annual Quote

NIH Pledges $3M for Pharmacogenomics Studies of Mood and Anxiety Disorders

NEW YORK, Sept. 5 (GenomeWeb News) - The National Institutes of Health announced today that it will commit $3 million in financial year 2004 to fund the use of genomic methods to track responses to drugs used to treat mood or anxiety disorders.

 

"The underlying theme of this RFA will be to search across the genome for pharmacogenetically important sequence variations by correlating genotype with treatment response," the Request for Applications stated. A particular focus, according to the NIH, will be the construction of haplotypes for pharmacogenetic prediction.

 

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.